Generated: May 28, 2017
|Title:||Treatment and prevention of risk factors for cardiovascular diseases|
|Abstract:||Fatty acid composition comprising at least 80% by weight of omega--3-fatty acids, salts or derivatives thereof, wherein (all-Z)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z)-4,7,10,13,16,19-docosahexaenoic acid comprises at least 75% by weight of the total fatty acids. The compositions can be used for the treatment or prophylaxis of multiple risk factors for cardiovascular diseases.|
|Inventor(s):||Breivik; Harald (Skjelsvik, NO), B.o slashed.rretzen; Bernt (Porsgrunn, NO), Dahl; Knut Helk.ang.s (Ulefoss, NO), Krokan; Hans Einar (Sjetnemarka, NO), B.o slashed.naa; Kaare Harold (Troms.o slashed., NO)|
|Assignee:||Norsk Hydro a.s (Oslo, NO)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Delivery;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|United Kingdom||8819110||Aug 11, 1988|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.